| Factor Information | |
|---|---|
| Data ID | 1697 |
| Factor | Height (cm) |
| Description | Height, weight, and BMI were significantly lower in both the CHD group and PHCHD group compared with the control group, while the difference between CHD group and PH-CHD group was not significant. |
| Biomarker | NA |
| Classification | E11 (physiological factor - physical sign) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | This study aims to estimate plasma levels of acylated ghrelin in children with pulmonary hypertension (PH) associated with congenital heart disease (CHD) and to correlate the levels of acylated ghrelin with endothelin-1 (ET-1), nitric oxide (NO), and clinical hemodynamic parameters. |
| p Value | 0.016 |
| Conclusion | Height, weight, and BMI were significantly lower in both the CHD group and PH-CHD group compared with the control group, while the difference between CHD group and PH-CHD group was not significant. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 548 |
| CHD Type | isolated CHD |
| CHD Subtype | VSD/ASD/PDA/other |
| Reference | |
|---|---|
| PMID | 25981561 |
| Year | 2015 |
| Title | Plasma Levels of Acylated Ghrelin in Children with Pulmonary Hypertension Associated with Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | blood | |
| Region | Luzhou, China | |
| Method | N/A | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | right heart catheterization | |
| Group | CHD-PAH children(Treatment) | control children(Control) |
| Number | 20 | 20 |
| Age | 35.9 ± 20.9 months | 35.1 ± 12.8 months |
| Gender (Male: Female) | 13:7 | 8:12 |
| Marker Level | 85.3 ± 11.1 cm | 93.1 ± 8.3 cm |
